Mühl H, Kämpfer H, Bosmann M, Frank S, Radeke H, Pfeilschifter J
Zentrum der Pharmakologie, Klinikum der Johann Wolfgang Goethe-Universität Frankfurt am Main, Frankfurt am Main, Germany.
Biochem Biophys Res Commun. 2000 Jan 27;267(3):960-3. doi: 10.1006/bbrc.1999.2064.
Interleukin-18 (IL-18) binding protein is a soluble decoy receptor for IL-18 which efficiently antagonizes biological functions of IL-18 in vitro and in vivo. Since regulation of IL-18 activity likely contributes to the pathogenesis of inflammatory diseases as well as malignancies, we investigated gene expression of IL-18 binding protein (IL-18BP) in different human cell systems, namely in the keratinocyte cell line HaCaT, in the colon carcinoma cell line DLD-1, and in primary renal mesangial cells. In unstimulated cells only minute amounts of mRNA coding for IL-18 binding protein were detectable. However, in all three cell types gene expression was markedly upregulated by interferon-gamma (IFN-gamma). IL-18 is recognized as a pivotal mediator of IFN-gamma production. Therefore, the present data imply that activity of IL-18 is modulated by a negative feedback mechanism which is mediated by IFN-gamma-induced IL-18 binding protein.
白细胞介素-18(IL-18)结合蛋白是一种可溶性IL-18诱饵受体,在体外和体内均能有效拮抗IL-18的生物学功能。由于IL-18活性的调节可能与炎症性疾病以及恶性肿瘤的发病机制有关,我们研究了IL-18结合蛋白(IL-18BP)在不同人类细胞系统中的基因表达,即角质形成细胞系HaCaT、结肠癌细胞系DLD-1和原代肾系膜细胞。在未受刺激的细胞中,仅能检测到微量编码IL-18结合蛋白的mRNA。然而,在所有这三种细胞类型中,干扰素-γ(IFN-γ)均可显著上调基因表达。IL-18被认为是IFN-γ产生的关键介质。因此,目前的数据表明,IL-18的活性受到一种负反馈机制的调节,该机制由IFN-γ诱导的IL-18结合蛋白介导。